Natco Pharma Share Price Today (1 December 2025): Q2 Results, USFDA Update, Adcock Ingram Deal & 2026 Forecast
Natco Pharma shares jumped nearly 5% to around ₹921 on the NSE by 11:05 am IST Friday, with volumes nearing 2.95 million. The rally follows Q2 FY26 results showing flat revenue at ₹1,363 crore and a 23% drop in net profit to ₹517.9 crore, as Revlimid profits fade and costs rise. Management expects little Revlimid contribution from Q3 onward but has kept full-year PAT guidance at ₹13 billion.
